Back
Qiagen NV 10K Form
Sell
43
QGEN
Qiagen NV
Last Price:
$41.97
Seasonality Move:
3.23%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive QGEN News And Ratings
See the #1 stock for the next 7 days that we like better than QGEN
QGEN Financial Statistics
Sales & Book Value
| Annual Sales: | $2B |
|---|---|
| Cash Flow: | $141.9M |
| Price / Cash Flow: | 18.35 |
| Annual Sales: | $16.51 |
| Price / Book: | 2.54 |
Profitability
| EPS (TTM): | 0.37400 |
|---|---|
| Net Income (TTM): | $83.6M |
| Gross Margin: | $967.4M |
| Return on Equity: | 2.33% |
| Return on Assets: | 1.42% |
Qiagen NV Earnings Forecast
Key Qiagen NV Financial Ratios
-
The Gross Profit Margin over the past 30 years for QGEN is 48.90%.
-
The Selling, General & Administrative Expenses for QGEN have been equal to 28.53% of Gross Profit Margin.
-
The Research & Development expenses have been 9.78% of Revenue.
-
The Interest Expense is 52.45% of Operating Income.
-
The Net Earning history of QGEN is 4.23% of Total Revenues.
-
Per Share Earnings over the last 30 years have been positive in 18 years.
Qiagen NV Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NYSE |
|---|---|
| Industry: | Life Sciences Tools & Services |
| Sector: | Health Care |
| Current Symbol: | QGEN |
| CUSIP: | N72482 |
| Website: | qiagen.com |
Debt
| Debt-to-Equity Ratio: | 0.39 |
|---|---|
| Current Ratio: | 3.61 |
| Quick Ratio: | 2.76 |
Price-to-Earnings
| Trailing P/E Ratio: | 110.31 |
|---|---|
| Forward P/E Ratio: | 16.84 |